IMIC(SZ:000516) Sou Hu Cai Jing·2026-01-14 10:41Group 1 - The core point of the news is that International Medicine (000516) has seen significant share pledges from its major shareholders, indicating potential liquidity issues [1] - Shareholder Shaanxi Century Xinyuan Commercial Management Co., Ltd. has pledged a total of 75 million shares, accounting for 3.35% of the total share capital [1] - As of the announcement date, Shaanxi Century Xinyuan has pledged a total of 506 million shares, which is 82.07% of its total holdings, while shareholder Shenhua Holdings Group Co., Ltd. has pledged 45.31 million shares, representing 74.91% of its holdings [1] Group 2 - International Medicine reported a revenue of 2.995 billion yuan for the first three quarters of 2025, a year-on-year decrease of 16.94% [1] - The net profit attributable to shareholders was -294 million yuan, down 38.45% year-on-year, and the net profit after deducting non-recurring gains and losses was -312 million yuan, a decline of 41.94% [1] - In Q3 2025, the company recorded a single-quarter revenue of 961 million yuan, a decrease of 18.95% year-on-year, with a net profit of -129 million yuan, reflecting a significant drop of 234.24% [1] - The company's debt ratio stands at 68.8%, with investment income of 20.7586 million yuan and financial expenses of 111 million yuan, resulting in a gross profit margin of 6.59% [1] Group 3 - The main business of International Medicine includes health care services and the application of modern medical technology [2]